Pediatric Infection and Vaccine

The Korean Society of Pediatric Infectious Diseases (대한소아감염학회)
권호 표지
DOI QR코드

DOI QR Code

Clinical Characteristics of Pertussis Epidemic in Changwon

창원에서 유행한 백일해의 임상적 특징

  • Jang, Joon Weon (Department of Pediatrics, College of Medicine, The Catholic University of Korea) ;
  • Kang, Jin Han (Department of Pediatrics, College of Medicine, The Catholic University of Korea) ;
  • Choi, Jae Won (Department of Pediatrics, Changwon Fatima Hospital) ;
  • Lee, Hak Sung (Department of Pediatrics, Changwon Fatima Hospital) ;
  • Ma, Sang Hyuk (Department of Pediatrics, Changwon Fatima Hospital)
  • 장준원 (가톨릭대학교 의과대학 소아과학교실) ;
  • 강진한 (가톨릭대학교 의과대학 소아과학교실) ;
  • 최재원 (창원파티마병원 소아과학교실) ;
  • 이학성 (창원파티마병원 소아과학교실) ;
  • 마상혁 (창원파티마병원 소아과학교실)
  • Received : 2016.08.10
  • Accepted : 2016.10.27
  • Published : 2017.04.25
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Pertussis can be prevented with a vaccine. Despite this, there have been an increasing number of cases worldwide, and also in Korea. This study aimed to investigate the epidemiology and clinical characteristics of the recent outbreak in the Changwon area. Methods: Patients who visited Changwon Fatima Hospital from July 2015 to March 2016 with respiratory symptoms, including spasmodic cough, cough induced vomiting, inspiratory 'intake' sound (whooping), and a night-time cough for >1 week were included in this study. Respiratory specimens were collected from patients and a polymerase chain reaction (PCR) and detected anti-pertussis immunoglobulin G enzyme-linked immunosorbent assay kit test were performed. Patients with underlying diseases, or those who had received a DTaP or Tdap vaccination in recent 1 year were excluded. Results: Pertussis was diagnosed in 37 of 50 patients, two patients were positive according to the PCR, and 37 patients were positive according to serologic tests. The age distribution of the patients was 1 month to 15 years. After administering antibiotics, all patients recovered without complications. Conclusions: A pertussis outbreak occurred in Changwon in 2015 and 2016. This data can provide the basis for further study on the epidemiology of pertussis in Korea.

목적: 백일해는 백신접종으로 예방이 가능한 질환이지만 세계적으로 증가하고 있고, 국내에서도 환자가 증가하고 있는 추세이다. 저자들은 최근 창원 지역에서 발생한 백일해 환자의 역학적인 특징과 임상 양상을 알아보고자 이 연구를 실시하였다. 방법: 2015년 7월부터 2016년 3월까지 호흡기 증상을 주소로 창원파티마병원 소아청소년과에 내원하는 환자 중 1주 이상의 기침을 하면서 발작적인 기침, 기침 후 구토, 흡기 시 '흡' 소리(whooping), 야간 기침이 동반된 환자들을 대상으로 호흡기 검체를 채취하여 백일해에 대한 배양, 중합연쇄반응검사를 실시하였고, 혈액의 항백일해 독소 항체검사(anti-pertussis toxin of ELISA kit, IBL International GmbH)를 실시하였다. 기저에 질환이 있거나 최근 1년 안에 DTaP 혹은 Tdap 백신 접종을 한경우에는 제외하였다. 결과: 연구 기간 동안 대상 환자 50명 중 진단된 환자는 37명이었다. 이 중 중합연쇄반응검사에서 양성인 환자는 2명이었고 혈청검사에서 양성인 환자는 37명이었다. 환자의 연령은 생후 1개월부터 15세였다. 항생제 사용 후 모든 환자가 합병증 없이 회복되었다. 결론: 2015년 7월부터 2016년 3월까지 창원 지역에 백일해의 유행이 있었으며, 이 연구 결과는 향후 국내에서 발생하는 백일해 역학 연구에 도움이 될 것으로 판단한다.

Keywords

References

  1. Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005;18:326-82. https://doi.org/10.1128/CMR.18.2.326-382.2005
  2. World Health Organization. Immunization, vaccines and biologicals: pertussis [Internet]. Geneva: World Health Organization; 2016 [cited 2016 Dec 23]. Available from: http://www.who.int/immunization/monitoring_surveillance/burden/vpd/surveillance_type/passive/pertussis/en/.
  3. Choe YJ, Kim JW, Park YJ, Jung C, Bae GR. Burden of pertussis is underestimated in South Korea: a result from an active sentinel surveillance system. Jpn J Infect Dis 2014;67: 230-2. https://doi.org/10.7883/yoken.67.230
  4. Korea Centers for Disease Control and Prevention. Increased whooping cough, proper vaccination is important [Internet]. Cheongju: Korea Centers for Disease Control and Prevention; 2012 [cited 2016 Dec 23]. Available from: http://www.cdc.go.kr/CDC/intro/CdcKrIntro0201.jsp?menuIds=HOME001-MNU1154-MNU0005-MNU0011&cid=64155.
  5. Zhang Q, Zheng H, Liu M, Han K, Shu J, Wu C, et al. The seroepidemiology of immunoglobulin G antibodies against pertussis toxin in China: a cross sectional study. BMC Infect Dis 2012;12:138. https://doi.org/10.1186/1471-2334-12-138
  6. Regan J, Lowe F. Enrichment medium for the isolation of Bordetella. J Clin Microbiol 1977;6:303-9.
  7. IBL International GmbH. Bordetella pertussis IgG ELISA [Internet]. Hamburg: IBL International GmbH; c2015 [cited Dec 23]. Available from: http://www.ibl-international. com/media/catalog/product/R/E/RE56141_IFU_EU_en_Bordetella_IgG_ELISA_2013-05_sym4.pdf.
  8. European Centre for Disease Prevention and Control. Guidance and protocol for the use of real-time PCR in laboratory diagnosis of human infection with Bordetella pertussis or Bordetella parapertussis. Stockholm: ECDC, 2012.
  9. Souder E, Long SS. Pertussis in the era of new strains of Bordetella pertussis. Infect Dis Clin North Am 2015;29:699-713. https://doi.org/10.1016/j.idc.2015.07.005
  10. Centers for Disease Control and Prevention (CDC). Pertussis epidemic: Washington, 2012. MMWR Morb Mortal Wkly Rep 2012;61:517-22.
  11. Martin SW, Pawloski L, Williams M, Weening K, DeBolt C, Qin X, et al. Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage. Clin Infect Dis 2015;60:223-7. https://doi.org/10.1093/cid/ciu788
  12. Winter K, Glaser C, Watt J, Harriman K; Centers for Disease Control and Prevention (CDC). Pertussis epidemic: California, 2014. MMWR Morb Mortal Wkly Rep 2014;63:1129-32.
  13. Choe YJ, Park YJ, Jung C, Bae GR, Lee DH. National pertussis surveillance in South Korea 1955-2011: epidemiological and clinical trends. Int J Infect Dis 2012;16:e850-4. https://doi.org/10.1016/j.ijid.2012.07.012
  14. Jung SW. Epidemiologic properties of pertussis confirmed from pharyngitis patients. Public Health Wkly Rep 2011;4: 237-40.
  15. Park S, Lee SH, Seo KH, Shin KC, Park YB, Lee MG, et al. Epidemiological aspects of pertussis among adults and adolescents in a Korean outpatient setting: a multicenter, PCRbased study. J Korean Med Sci 2014;29:1232-9. https://doi.org/10.3346/jkms.2014.29.9.1232
  16. Lee SY, Han SB, Kang JH, Kim JS. Pertussis prevalence in Korean adolescents and adults with persistent cough. J Korean Med Sci 2015;30:988-90. https://doi.org/10.3346/jkms.2015.30.7.988
  17. Cherry JD. The epidemiology of pertussis and pertussis immunization in the United Kingdom and the United States: a comparative study. Curr Probl Pediatr 1984;14:1-78.
  18. Solano R, Crespo I, Fernandez MI, Valero C, Alvarez MI, Godoy P, et al. Underdetection and underreporting of pertussis in children attended in primary health care centers: Do surveillance systems require improvement? Am J Infect Control 2016;44:e251-6. https://doi.org/10.1016/j.ajic.2016.03.033
  19. Cherry JD, Tan T, Wirsing von Konig CH, Forsyth KD, Thisyakorn U, Greenberg D, et al. Clinical definitions of pertussis: summary of a Global Pertussis Initiative roundtable meeting, February 2011. Clin Infect Dis 2012;54:1756-64. https://doi.org/10.1093/cid/cis302
  20. Campins-Marti M, Cheng HK, Forsyth K, Guiso N, Halperin S, Huang LM, et al. Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration. Vaccine 2001;20:641-6. https://doi.org/10.1016/S0264-410X(01)00393-0
  21. Cherry JD, Grimprel E, Guiso N, Heininger U, Mertsola J. Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives. Pediatr Infect Dis J 2005;24(5 Suppl):S25-34. https://doi.org/10.1097/01.inf.0000160926.89577.3b
  22. Rendi-Wagner P, Tobias J, Moerman L, Goren S, Bassal R, Green M, et al. The seroepidemiology of Bordetella pertussis in Israel: estimate of incidence of infection. Vaccine 2010;28: 3285-90. https://doi.org/10.1016/j.vaccine.2010.02.104
  23. Narkeviciute I, Kavaliunaite E, Bernatoniene G, Eidukevicius R. Clinical presentation of pertussis in fully immunized children in Lithuania. BMC Infect Dis 2005;5:40. https://doi.org/10.1186/1471-2334-5-40
  24. Bodilis H, Guiso N. Virulence of pertactin-negative Bordetella pertussis isolates from infants, France. Emerg Infect Dis 2013;19:471-4. https://doi.org/10.3201/eid1903.121475
  25. Brotons P, de Paz HD, Toledo D, Villanova M, Plans P, Jordan I, et al. Differences in Bordetella pertussis DNA load according to clinical and epidemiological characteristics of patients with whooping cough. J Infect 2016;72:460-7. https://doi.org/10.1016/j.jinf.2016.01.013
  26. Crowcroft NS, Booy R, Harrison T, Spicer L, Britto J, Mok Q, et al. Severe and unrecognised: pertussis in UK infants. Arch Dis Child 2003;88:802-6. https://doi.org/10.1136/adc.88.9.802
  27. Halperin SA, Wang EE, Law B, Mills E, Morris R, Dery P, et al. Epidemiological features of pertussis in hospitalized patients in Canada, 1991-1997: report of the Immunization Monitoring Program: Active (IMPACT). Clin Infect Dis 1999;28:1238-43. https://doi.org/10.1086/514792
  28. Pierce C, Klein N, Peters M. Is leukocytosis a predictor of mortality in severe pertussis infection? Intensive Care Med 2000;26:1512-4. https://doi.org/10.1007/s001340000587
  29. Centers for Disease Control and Prevention. Diagnosis confirmation [Internet]. Atlanta: Centers for Disease Control and Prevention; 2015 [cited Dec 23]. Available from: http://www.cdc.gov/pertussis/clinical/diagnostic-testing/diagnosisconfirmation.html.
  30. Andre P, Caro V, Njamkepo E, Wendelboe AM, Van Rie A, Guiso N. Comparison of serological and real-time PCR assays to diagnose Bordetella pertussis infection in 2007. J Clin Microbiol 2008;46:1672-7. https://doi.org/10.1128/JCM.02187-07
  31. Riffelmann M, Thiel K, Schmetz J, Wirsing von Koenig CH. Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis. J Clin Microbiol 2010;48:4459-63. https://doi.org/10.1128/JCM.01371-10
  32. Altunaiji S, Kukuruzovic R, Curtis N, Massie J. Antibiotics for whooping cough (pertussis). Cochrane Database Syst Rev 2007;(3):CD004404.
  33. Langley JM, Halperin SA, Boucher FD, Smith B; Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC). Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis. Pediatrics 2004;114:e96-101. https://doi.org/10.1542/peds.114.1.e96
  34. Wood N, McIntyre P. Pertussis: review of epidemiology, diagnosis, management and prevention. Paediatr Respir Rev 2008;9:201-11. https://doi.org/10.1016/j.prrv.2008.05.010

Cited by

  1. A systematic review of the burden of pertussis in South Korea vol.17, pp.6, 2021, https://doi.org/10.1080/21645515.2020.1844505